A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine

HIGHLIGHTS

• who: Johanne U. Hermansen from the Patient material and ethical considerations Blood samples from CLL patients were received from the Department of Haematology, Oslo University Hospital, NorwayAll participants signed a written informed consent prior to sample collection. The study was approved by the Regional Committee for Medical and Health Research have published the research work: A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine, in the Journal: (JOURNAL) of 21/Nov/2022
• what: The authors aimed to develop a standardized microenvironment model that is compatible with ex vivo . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.